Epigenetic dysregulation and therapeutic targeting of <scp>RET</scp> receptor tyrosine kinase in high‐risk <scp> <i>KMT2A</i> </scp> ‐rearranged acute myeloid leukaemia

The authors declare that they have no known competing financial interests or personal relationships that could be perceived as influencing the work presented in this paper. The RNA sequencing data for 8p-treated MOLM-13 cells have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE291525. The remaining data are available from the corresponding author upon reasonable request. Figure S1. Table S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.